Efficacy of Generic Imatinib After Switching from Original in Treatment of Patients with Chronic Myeloid Leukemia in the Republic of North Macedonia - A Single-Center Experience

被引：0
|
作者：
Dukovski, Dushko [1 ]
Trajkova, Sanja [1 ]
Stojanovska, Simona [1 ]
Ridova, Nevenka [1 ]
Panovska-Stavridis, Irina [1 ]
机构：
[1] Clin Hematol, Skopje, North Macedonia
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2020年 / 20卷
关键词：
CML; imatinib; selective tyrosine kinase inhibitor (TKI); chronic myeloid leukemia;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CML-104
引用
收藏
页码：S232 / S232
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of generic imatinib after switching from original imatinib in patients treated for chronic myeloid leukemia in the United States
    Abou Dalle, Iman
    Kantarjian, Hagop
    Burger, Jan
    Estrov, Zeev
    Ohanian, Maro
    Verstovsek, Srdan
    Ravandi, Farhad
    Borthakur, Gautam
    Garcia-Manero, Guillermo
    Jabbour, Elias
    Cortes, Jorge
    CANCER MEDICINE, 2019, 8 (15): : 6559 - 6565
  • [2] Efficacy and Safety of Imatinib Treatment in Elderly Patients With Chronic Myeloid Leukemia: Real-Life Data and a Single-Center Experience
    Eskazan, Ahmet Emre
    Ozmen, Deniz
    Oztas, Mert
    Bektas, Fatih
    Bayraktar, Esref Alperen
    Sadri, Sevil
    Keskin, Dilek
    Yurttas, Nurgul Ozgur
    Elverdi, Tugrul
    Salihoglu, Ayse
    Ar, Muhlis Cem
    Ongoren, Seniz
    Baslar, Zafer
    Aydin, Yildiz
    Soysal, Teoman
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (08) : 549 - 557
  • [3] Clinical efficacy and safety of imatinib treatment in children and adolescents with chronic myeloid leukemia: A single-center experience in China
    Deng, Mengyue
    Guan, Xianmin
    Wen, Xianhao
    Xiao, Jianwen
    An, Xizhou
    Yu, Jie
    MEDICINE, 2020, 99 (07)
  • [4] Pediatric chronic myeloid leukemia: A single-center experience
    Madabhavi, Irappa
    Patel, Apurva
    Modi, Gaurang
    Anand, Asha
    Panchal, Harsha
    Parikh, Sonia
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2020, 16 (01) : 110 - 115
  • [5] Generic imatinib in the treatment of chronic myeloid leukemia: Cerrahpasa experience
    Eskazan, Ahmet Emre
    Soysal, Teoman
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2016, 22 (02) : 382 - 384
  • [6] Hematologic, cytogenetic, and molecular responses to imatinib therapy for chronic myeloid leukemia: a single-center experience in Turkey
    Bilen, Yusuf
    Erdem, Fuat
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2012, 42 (01) : 31 - 38
  • [7] Prospective single-center study of chronic myeloid leukemia in chronic phase: switching from branded imatinib to a copy drug and back
    Alwan, Alaa Fadhil
    Matti, Bassam F.
    Naji, Aladdin S.
    Muhammed, Abdulsalam H.
    Abdulsahib, Manal A.
    LEUKEMIA & LYMPHOMA, 2014, 55 (12) : 2830 - 2834
  • [8] Real-world Experience of Imatinib in Pediatric Chronic Phase Chronic Myeloid Leukemia: A Single-center Experience From India
    Ganguly, Shuvadeep
    Pushpam, Deepam
    Mian, Agrima
    Chopra, Anita
    Gupta, Ritu
    Bakhshi, Sameer
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (07) : E437 - E444
  • [9] Good adherence to imatinib therapy among patients with chronic myeloid leukemia—a single-center observational study
    Sofia Jönsson
    Bob Olsson
    Jenny Söderberg
    Hans Wadenvik
    Annals of Hematology, 2012, 91 : 679 - 685
  • [10] Response to imatinib therapy in adult patients with chronic myeloid leukemia in Saudi population: a single-center study
    Alsobhi, Enaam
    Abrar, Mohammed Burhan
    Abdelaal, Mohammed
    Alsaeed, Ahmed
    Absi, Ahmed
    Alzahrani, Zayed
    El-Hennaidi, Lhab
    Alshehri, Mohammed Ali
    Warsi, Ashraf
    Bayashoot, Safaa
    Hashem, Heba
    Merdad, Anas
    Radi, Suhaib
    Shiekhi, Hanadi
    Al-Amri, Abdulfattah
    LEUKEMIA & LYMPHOMA, 2015, 56 (04) : 882 - 886
12345